首页> 外文期刊>Neurosurgery >An Outcome Study for Ulnar Neuropathy at the Elbow: A Multicenter Study by the Surgery for Ulnar Nerve (SUN) Study Group
【24h】

An Outcome Study for Ulnar Neuropathy at the Elbow: A Multicenter Study by the Surgery for Ulnar Nerve (SUN) Study Group

机译:肘部尺神经病的结果研究:尺神经外科研究小组的多中心研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Many instruments have been developed to measure upper extremity disability, but few have been applied to ulnar neuropathy at the elbow (UNE). OBJECTIVE: We measured patient outcomes following ulnar nerve decompression to (1) identify the most appropriate outcomes tools for UNE and (2) to describe outcomes following ulnar nerve decompression.METHODS: Thirty-nine patients from 5 centers were followed prospectively after nerve decompression. Outcomes were measured preoperatively and at 6 weeks, 3 months, 6 months, and 12 months postoperatively. Each patient completed the Michigan Hand Questionnaire (MHQ), Carpal Tunnel Questionnaire (CTQ), and Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaires. Grip, key-pinch strength, Semmes-Wejnstein monofilament, and 2-point discrimination were measured. Construct validity was calculated by using Spearman correlation coefficients between questionnaire scores and physical and sensory measures. Responsiveness was assessed by standardized response means. RESULTS: Key-pinch (P = .008) and Semmes-Weinstein monofilament testing of the ulnar ring (P < .001) and small finger (radial: P = .004; ulnar: P < .001) improved following decompression. Two-point discrimination improved significantly across the radial (P = .009) and ulnar (P = .007) small finger. Improved symptoms and function were noted by the CTQ (preoperative CTQ symptom score 2.73 vs 1.90 postoperatively, P < .001), DASH (P < .001), and MHQ: function (P < .001), activities of daily living (P = .003), work (P = .006), pain (P < .001), and satisfaction (P < .001). All surveys demonstrated strong construct validity, defined by correlation with functional outcomes, but MHQ and CTQ symptom instruments demonstrated the highest responsiveness. CONCLUSION: Patient-reported outcomes improve following ulnar nerve decompression, including pain, function, and satisfaction. The MHQ and CTQ are more responsive than the DASH for isolated UNE treated with decompression.
机译:背景:已开发出许多工具来测量上肢残疾,但很少用于肘部尺神经病(UNE)。目的:我们测量尺神经减压后的患者预后,以(1)确定最合适的UNE预后工具,(2)描述尺神经减压后的预后。方法:神经减压后,对5个中心的39例患者进行了随访。术前和术后6周,3个月,6个月和12个月测量结果。每位患者均填写了密歇根州手调查表(MHQ),腕管调查表(CTQ)和手臂,肩膀和手部残疾(DASH)问卷。测量抓地力,键捏强度,Semmes-Wejnstein单丝和2点分辨力。通过使用问卷得分与身体和感觉指标之间的Spearman相关系数来计算构建体有效性。响应性通过标准化响应方式进行评估。结果:减压后,尺骨环(P <.001)和小指(radi骨:P = .004;尺骨:P <.001)的捏捏(P = .008)和Semmes-Weinstein单丝测试改善。小指的radial骨(P = .009)和尺骨(P = .007)的两点识别效果显着改善。 CTQ的症状和功能得到改善(术前CTQ症状评分2.73 vs手术后1.90,P <.001),DASH(P <.001)和MHQ:功能(P <.001),日常生活活动(P = .003),工作(P = .006),疼痛(P <.001)和满意度(P <.001)。所有调查均显示出强大的结构效度,其定义与功能结局相关,但MHQ和CTQ症状仪器显示出最高的响应度。结论:尺神经减压后患者报告的结局改善,包括疼痛,功能和满意度。对于单独的经减压治疗的UNE,MHQ和CTQ比DASH更具响应性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号